Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
YY Group Holding Limited Projects US$28 Million for New Integrated Facility Management Division Following Property Facility Services Pte. Ltd. Acquisition
-
Apollo Advances Financial Advisor Education and Access to Alternative Investments with Launch of Apollo Allocation Pro
-
Jupiter Neurosciences Announces JOTROL Manufacturing Agreement with Catalent to Support Phase 2a Parkinson’s Trial
-
Taseko Comments on New US and Canadian Tariffs
-
LiveOne (NASDAQ: LVO) and Telly Partner to Elevate the Home Entertainment Experience
-
Meltwater Announces New Integration with Snapchat for Social Listening
-
Beyond, Inc. Scheduled to Release Fourth Quarter & Full Year 2024 Financial Results
-
89bio Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
LeddarTech Announces First OEM Design Win for LeddarVision ADAS Solution
-
Matthews Highlights Significant Shareholder Support and Underscores Board’s Commitment to Long-Term Value Creation
-
Australian Oilseeds Accelerates Growth with Expanded Distribution Across 1,000+ Woolworths Stores
-
BOS Starts 2025 Growth Plans with a New $2.3 Million Defense Related Order
-
Talkspace to Report Fourth Quarter and Full Year 2024 Results and Host Conference Call
-
Akari Therapeutics Joins Webull Corporate Connect Service Platform
-
Salarius Pharmaceuticals Announces Patient Enrollment to Resume in Investigator-initiated Phase 1/2 Clinical Trial Using Seclidemstat with Azacitidine to Treat Hematologic Cancers
-
illumin to Present at the Small Cap Growth Virtual Investor Conference on February 6th
-
A-Mark Expands Product Portfolio into Collectibles by Acquiring the Parent of Stack’s Bowers Galleries, A Leading Global Rare Coin Auction House and Dealer
-
Ollie’s Bargain Outlet Announces the Appointment of Eric van der Valk to President & Chief Executive Officer, Completing Leadership Succession Plan
-
Spur Therapeutics Announces Successful End-of-Phase 2 Meeting with FDA for FLT201, Its Gene Therapy Candidate for Gaucher Disease
-
Southern Realty Trust Commits $20.0 Million to a Senior Loan for Shell Plaza at River District in New Orleans, Louisiana
-
Sunrise Realty Trust, Inc. Commits $44.0 Million to a Senior Loan for Shell Plaza at the River District in New Orleans, Louisiana
-
FLYR Welcomes Thomas Fuss as Chief Technology Officer
-
Arteris to Announce Financial Results for the Fourth Quarter and Year End 2024 on Tuesday, February 18, 2025
-
Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Sysco to Webcast Presentation at the CAGNY 2025 Conference
-
Vaisala's Financial Statement Release January–December 2024 to be published on February 18, 2025
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
Beyond, Inc. Scheduled to Release Fourth Quarter & Full Year 2024 Financial Results
-
Form 8.3 - Warpaint London Plc
-
Form 8.3 - Renewi Plc
-
Wearable Devices Unveils the LLM of Gesture Control: Large MUAP Models (LMM) Set to Revolutionize Human-Computer Interaction
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
Shares for Interest Debt Settlement
-
Northfield Capital Announces Changes to the Board of Directors
-
DDB Miner Expands Cloud Mining Solutions, Offering Users a Path to Financial Freedom
-
Scleroseforeningen choose Agillic for personalised member engagement and community impact
-
Topicus.com Inc. announces Shareholders’ Agreement
-
Digihost Provides January 2025 Production Update
-
FTI Consulting Announces Technology Alliance with iManage
-
TILT Holdings Signs Definitive Agreement to Divest Retail Locations in Massachusetts to In Good Health for $2 Million
-
BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™
-
American Tungsten Corp. Strengthens Strategic Position as Domestic Tungsten Supplier Amid U.S.-Canada Tariffs
-
Tyson Foods Reports First Quarter 2025 Results
-
NFI schedules fourth quarter and full year 2024 financial results
-
Itafos Continues With Outstanding Operational Performance, Provides Q4 2024 Operational Update
-
OREA presents ten bold housing solutions for the 2025 provincial election
-
Safe Harbor Financial Announces Temporary Pause in Principal Payments and Ongoing Discussions to Modify Promissory Note with PCCU
-
nCino Announces Appointment of Sean Desmond as President and Chief Executive Officer
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Dyne Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
